Vivet Therapeutics

Vivet Therapeutics is a biotech company in Paris, France, founded in 2016. It has raised $43.7M across 1 round, most recently a $43.7M Series A in April 2017.

Accueil

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$43.7M
Last Round
$43.7M Series AApr 2017
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Vivet Therapeutics is a clinical-stage biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases. It is building a diversified pipeline on recombinant adeno-associated virus (rAAV) technologies licensed from FIMA at CIMA, University of Navarra in Pamplona, Spain. Programs include VTX-PID to help patients with pre-existing AAV antibodies access gene therapy, VTX-806 for cerebrotendinous xanthomatosis, and VTX-801 for Wilson's disease. The company is backed by investors including Novartis Venture Fund, Roche Venture Fund, HealthCap, and Pfizer.

Summary

It lists 11–50 employees. It has raised $43.7M in total across 1 round, most recently a $43.7M Series A round in Apr 2017.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2017
$43.7M

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vivet Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vivet-therapeutics"><img src="https://indexed.vc/api/badge/company/vivet-therapeutics" alt="Vivet Therapeutics on Indexed.vc" width="260" height="76" /></a>